Trial To Assess The Lipid-Lowering Effect Of Adding Tenofovir/Emtricitabine Co-Formulation Vs Placebo To Hiv-1-Infected Subjects With Dyslipidemia And Sustained Viral Load Suppression Under Monotherapy With Ritonavir-Boosted Protease Inhibitors

Clinical trial NCT01458977 · COMPLETED

Trial details

NCT number

NCT01458977

Sponsor

Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia

Status

COMPLETED

Phase

Phase 4

Study type

INTERVENTIONAL

Start date

2012-01-01

Primary completion

2014-02-01

Enrollment

48

View on ClinicalTrials.gov